SIRT3 and prostate carcinoma: In contrast, SIRT3 was reported to suppress tumor growth via induction of growth arrest and apoptosis in colorectal carcinoma, osteosarcoma cells, ovarian cancer, prostate cancer, suggesting that SIRT3 is tumor suppressor in these cancers [9].